感染症分子診断のアメリカ市場2017-2021

【英語タイトル】2017-2021 US Infectious Disease Molecular Diagnostics Market: Test Volume and Sales Forecasts, Supplier Shares, Competitive Strategies, Innovative Technologies, Instrumentation Review

Venture Planning Groupが出版した調査資料(DATA70209033)・商品コード:DATA70209033
・発行会社(調査会社):Venture Planning Group
・発行日:2017年2月7日
・ページ数:1013
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:アメリカ
・産業分野:医療
◆販売価格オプション(消費税別)
Local PDF(同一事業所内共有可)USD6,200 ⇒換算¥700,600見積依頼/購入/質問フォーム
Global PDF(全事業所で共有可)USD13,600 ⇒換算¥1,536,800見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Complete report $6,200.  DataPack (test volumes, sales forecasts, supplier shares) $3,900.  The report is available by section, market segment, individual test, and can be custom-tailored to your specific information needs and budget.

This new study from VPGMarketResearch.com contains 1,013 pages, 62 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years.

Report Highlights

- Business and technological trends in major markets
- Five-year test volume and sales forecasts
- Market shares of leading competitors
- Feature comparison of major analyzers
- Strategic profiles of leading market players and start-up firms developing innovative products
- Specific product and business opportunities for instrument and consumable suppliers.

Rationale

The infectious disease molecular diagnostics market is one of the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.

In order to successfully capitalize on the opportunities presented by the infectious disease molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.

US Market Overview

- Laboratories performing DNA sequencing and molecular diagnostic testing for infectious diseases
  by market segment.

- Five-year test volume and sales projections.

Market Segmentation Analysis

- Sales and market shares of leading suppliers of infectious disease molecular diagnostic
  reagent kits and components.

- Five-year test volume and sales projections for over 40 infectious disease molecular diagnostic assays.

- A comprehensive analysis of the sequencing market by country and laboratory segment.
- Detailed market segmentation analysis, including review of the market dynamics, trends,
  structure, size, growth and major suppliers.

Product/Technology Review

- Comparison of leading infectious disease molecular diagnostic analyzers.

- Extensive review of molecular diagnostic technologies, test formats, detection methodologies,
  trends in testing automation and over target/signal amplification methods.

- Worldwide listings of companies, universities and research centers developing new molecular
  diagnostic technologies and products.

Competitive Assessments

- Extensive strategic assessments of major suppliers and emerging market entrants,
  including their sales, product portfolios, marketing tactics, collaborative arrangements
  and new technologies/products in R&D.
- Abbott
- Affymetrix
- Agilent Technologies
- Applied Gene Technologies
- Arca Biopharma
- Beckman Coulter/Danaher
- Becton Dickinson
- Biokit
- bioMerieux
- Bio-Rad
- Biotest
- CellMark Forensics/LabCorp
- Cepheid
- Decode Genetics
- Diadexus
- Eiken
- Elitech Group
- Enzo
- Exact Sciences
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- Illumina
- Kreatech
- Li-Cor Biosciences
- Monogram Biosciences/LabCorp
- Myriad Genetics
- Ortho-Clinical Diagnostics
- Perkin Elmer/Caliper
- Proteome Sciences
- Qiagen
- Roche
- Scienion
- Sequenom
- Shimadzu
- Siemens
- Sierra Molecular
- Takara Bio
- Tecan Group
- Thermo Fisher

- Comprehensive listings of companies developing and marketing infectious disease molecular
  Diagnostic products, by test and application.

Opportunities and Strategic Recommendations

- Specific new product development opportunities with potentially significant market appeal
  during the next five years.

- Design criteria for new products.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.
- Business planning issues and concerns.

Contains 1,013 pages and 62 tables


This new study from VPGMarketResearch.com contains 1,013 pages, 62 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years.

【レポートの目次】

http://www.vpgcorp.com/webfiles/DNA/TOCLOT%20USInfectiousDiseaseMolecularDiagnosticsMarket.pdf

http://www.vpgmarketresearch.com/pdffiles/LOTUSInfectiousDiseaseMolecularDiagnosticsMarket.pdf

【レポートのキーワード】

感染症分子診断

★調査レポート[感染症分子診断のアメリカ市場2017-2021] (コード:DATA70209033)販売に関する免責事項を必ずご確認ください。
★調査レポート[感染症分子診断のアメリカ市場2017-2021]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆